Co-Diagnostics, Inc.
Extract: Bylaws Amended/Restated (Plain English Desc) from a 10-Q on 11/07/2024   Download
SEC Document
SEC Filing

Effective as of November 4, 2024, the Board of Directors of Co-Diagnostics, Inc. (the “Company”), approved an amendment (the “Amendment”) to the Company’s Amended and Restated Bylaws (the “Bylaws”). The Amendment modifies the Company’s Bylaws to eliminate the classification of the Board of Directors and provide that all members of the Board of Directors are elected annually. The Amendment also makes various conforming changes to the Bylaws to reflect the de-classification of the Board of Directors.